Related Experiment Video
Updated: Feb 16, 2026
04:11
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
4.8K
Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray
Doo Hyun Kim1, Hong Seok Kang1, Seong-Suk Hur1
1Department of Pharmacology, Center for Cancer Research and Diagnostic Medicine, IBST, Seoul, Korea.
Gut and Liver
|December 23, 2017
Summary
A novel dendron-modified DNA microarray offers a rapid and efficient method for detecting drug-resistance mutations in hepatitis B virus (HBV). This advanced technique allows for direct analysis of patient sera, improving high-throughput screening for antiviral resistance.
Area of Science:
- Molecular Diagnostics
- Virology
- Biotechnology
Background:
- Direct sequencing, the standard for detecting hepatitis B virus (HBV) drug-resistance mutations, is slow and not suitable for high-throughput screening.
- Developing efficient methods for identifying genotypic resistance is crucial for managing HBV infection.
Purpose of the Study:
- To develop and evaluate a dendron-modified DNA microarray for detecting HBV genotypic resistance mutations.
- To assess the efficiency and diagnostic accuracy of this novel microarray technique.
Main Methods:
- Dendron-modified slides were developed and tested for specificity, sensitivity, and selectivity in detecting HBV drug-resistance mutations.
- Diagnostic accuracy was validated using sera from patients with viral breakthrough during antiviral therapy, comparing results with restriction fragment mass polymorphism and direct sequencing.
Main Results:
- Dendron-modified slides significantly outperformed conventional microarrays, detecting HBV DNA at levels as low as 1 copy/µL.
- HBV mutants were detectable directly in chronic hepatitis B patient sera without prior virus purification.
- The microarray technique demonstrated full compatibility with sequencing data for drug-resistant HBV.
Conclusions:
- A novel diagnostic technique using a dendron-modified DNA microarray was successfully developed for simultaneous detection of multiple drug-resistance mutations.
- This method is suitable for direct application to sera from chronic hepatitis B patients exhibiting resistance to nucleos(t)ide analogues, offering a significant advancement in diagnostic capabilities.
